vs
Resolute Holdings Management, Inc.（RHLD）与ROGERS CORP（ROG）财务数据对比。点击上方公司名可切换其他公司
ROGERS CORP的季度营收约是Resolute Holdings Management, Inc.的1.7倍（$200.5M vs $117.7M），ROGERS CORP净利率更高（2.2% vs -1.5%，领先3.7%），Resolute Holdings Management, Inc.自由现金流更多（$189.2M vs $1.1M）
Resolute Holdings Management, Inc.是一家澳大利亚矿业企业，核心业务布局于非洲地区，目前运营两座金矿，分别为位于马里的 Syama 金矿和塞内加尔的 Mako 金矿，专注于黄金资源的勘探、开采及相关运营管理工作。
罗杰斯公司是一家专注于特种工程材料研发生产的企业，总部位于美国亚利桑那州钱德勒市，其产品广泛应用于先进电子、移动通信、清洁能源、航空航天等多个高科技领域，为全球客户提供高性能材料解决方案。
RHLD vs ROG — 直观对比
营收规模更大
ROG
是对方的1.7倍
$117.7M
净利率更高
ROG
高出3.7%
-1.5%
自由现金流更多
RHLD
多$188.1M
$1.1M
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $117.7M | $200.5M |
| 净利润 | $-1.7M | $4.5M |
| 毛利率 | 55.7% | 32.2% |
| 营业利润率 | 30.2% | — |
| 净利率 | -1.5% | 2.2% |
| 营收同比 | — | 5.2% |
| 净利润同比 | — | 421.4% |
| 每股收益（稀释后） | $-0.20 | $0.25 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RHLDROG
| Q1 26 | — | $200.5M | ||
| Q4 25 | $117.7M | $201.5M | ||
| Q3 25 | $120.9M | $216.0M | ||
| Q2 25 | $119.6M | $202.8M | ||
| Q1 25 | $103.9M | $190.5M | ||
| Q4 24 | — | $192.2M | ||
| Q3 24 | — | $210.3M | ||
| Q2 24 | — | $214.2M |
净利润RHLDROG
| Q1 26 | — | $4.5M | ||
| Q4 25 | $-1.7M | $4.6M | ||
| Q3 25 | $-231.0K | $8.6M | ||
| Q2 25 | $-611.0K | $-73.6M | ||
| Q1 25 | $-3.4M | $-1.4M | ||
| Q4 24 | — | $-500.0K | ||
| Q3 24 | — | $10.7M | ||
| Q2 24 | — | $8.1M |
毛利率RHLDROG
| Q1 26 | — | 32.2% | ||
| Q4 25 | 55.7% | 31.5% | ||
| Q3 25 | 59.0% | 33.5% | ||
| Q2 25 | 57.5% | 31.6% | ||
| Q1 25 | 52.5% | 29.9% | ||
| Q4 24 | — | 32.1% | ||
| Q3 24 | — | 35.2% | ||
| Q2 24 | — | 34.1% |
营业利润率RHLDROG
| Q1 26 | — | — | ||
| Q4 25 | 30.2% | 3.5% | ||
| Q3 25 | 34.3% | 7.3% | ||
| Q2 25 | 34.0% | -33.3% | ||
| Q1 25 | 24.7% | -0.2% | ||
| Q4 24 | — | -6.6% | ||
| Q3 24 | — | 6.9% | ||
| Q2 24 | — | 5.3% |
净利率RHLDROG
| Q1 26 | — | 2.2% | ||
| Q4 25 | -1.5% | 2.3% | ||
| Q3 25 | -0.2% | 4.0% | ||
| Q2 25 | -0.5% | -36.3% | ||
| Q1 25 | -3.2% | -0.7% | ||
| Q4 24 | — | -0.3% | ||
| Q3 24 | — | 5.1% | ||
| Q2 24 | — | 3.8% |
每股收益（稀释后）RHLDROG
| Q1 26 | — | $0.25 | ||
| Q4 25 | $-0.20 | $0.20 | ||
| Q3 25 | $-0.03 | $0.48 | ||
| Q2 25 | $-0.07 | $-4.00 | ||
| Q1 25 | $-0.39 | $-0.08 | ||
| Q4 24 | — | $-0.04 | ||
| Q3 24 | — | $0.58 | ||
| Q2 24 | — | $0.44 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $205.5M | $195.8M |
| 总债务越低越好 | $169.8M | — |
| 股东权益账面价值 | $6.5M | $1.2B |
| 总资产 | $333.4M | $1.4B |
| 负债/权益比越低杠杆越低 | 26.03× | — |
8季度趋势，按日历期对齐
现金及短期投资RHLDROG
| Q1 26 | — | $195.8M | ||
| Q4 25 | $205.5M | $197.0M | ||
| Q3 25 | $148.0M | $167.8M | ||
| Q2 25 | $99.9M | $157.2M | ||
| Q1 25 | $71.0M | $175.6M | ||
| Q4 24 | — | $159.8M | ||
| Q3 24 | — | $146.4M | ||
| Q2 24 | — | $119.9M |
总债务RHLDROG
| Q1 26 | — | — | ||
| Q4 25 | $169.8M | — | ||
| Q3 25 | $173.4M | — | ||
| Q2 25 | $177.1M | — | ||
| Q1 25 | $180.7M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益RHLDROG
| Q1 26 | — | $1.2B | ||
| Q4 25 | $6.5M | $1.2B | ||
| Q3 25 | $10.8M | $1.2B | ||
| Q2 25 | $9.6M | $1.2B | ||
| Q1 25 | $8.9M | $1.3B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | — | $1.3B |
总资产RHLDROG
| Q1 26 | — | $1.4B | ||
| Q4 25 | $333.4M | $1.4B | ||
| Q3 25 | $293.2M | $1.4B | ||
| Q2 25 | $253.3M | $1.5B | ||
| Q1 25 | $214.3M | $1.5B | ||
| Q4 24 | — | $1.5B | ||
| Q3 24 | — | $1.5B | ||
| Q2 24 | — | $1.5B |
负债/权益比RHLDROG
| Q1 26 | — | — | ||
| Q4 25 | 26.03× | — | ||
| Q3 25 | 16.01× | — | ||
| Q2 25 | 18.42× | — | ||
| Q1 25 | 20.38× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $196.1M | $5.8M |
| 自由现金流经营现金流 - 资本支出 | $189.2M | $1.1M |
| 自由现金流率自由现金流/营收 | 160.8% | 0.5% |
| 资本支出强度资本支出/营收 | 5.8% | 2.3% |
| 现金转化率经营现金流/净利润 | — | 1.29× |
| 过去12个月自由现金流最近4个季度 | $313.2M | $70.1M |
8季度趋势，按日历期对齐
经营现金流RHLDROG
| Q1 26 | — | $5.8M | ||
| Q4 25 | $196.1M | $46.9M | ||
| Q3 25 | $59.6M | $28.9M | ||
| Q2 25 | $48.9M | $13.7M | ||
| Q1 25 | $18.4M | $11.7M | ||
| Q4 24 | — | $33.7M | ||
| Q3 24 | — | $42.4M | ||
| Q2 24 | — | $22.9M |
自由现金流RHLDROG
| Q1 26 | — | $1.1M | ||
| Q4 25 | $189.2M | $42.2M | ||
| Q3 25 | $58.6M | $21.2M | ||
| Q2 25 | $47.5M | $5.6M | ||
| Q1 25 | $17.8M | $2.1M | ||
| Q4 24 | — | $18.3M | ||
| Q3 24 | — | $25.2M | ||
| Q2 24 | — | $8.8M |
自由现金流率RHLDROG
| Q1 26 | — | 0.5% | ||
| Q4 25 | 160.8% | 20.9% | ||
| Q3 25 | 48.5% | 9.8% | ||
| Q2 25 | 39.7% | 2.8% | ||
| Q1 25 | 17.1% | 1.1% | ||
| Q4 24 | — | 9.5% | ||
| Q3 24 | — | 12.0% | ||
| Q2 24 | — | 4.1% |
资本支出强度RHLDROG
| Q1 26 | — | 2.3% | ||
| Q4 25 | 5.8% | 2.3% | ||
| Q3 25 | 0.8% | 3.6% | ||
| Q2 25 | 1.2% | 4.0% | ||
| Q1 25 | 0.6% | 5.0% | ||
| Q4 24 | — | 8.0% | ||
| Q3 24 | — | 8.2% | ||
| Q2 24 | — | 6.6% |
现金转化率RHLDROG
| Q1 26 | — | 1.29× | ||
| Q4 25 | — | 10.20× | ||
| Q3 25 | — | 3.36× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.96× | ||
| Q2 24 | — | 2.83× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
